Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and chop (R-CHOP) based chemotherapy

被引：0
|
作者：
Akhtar, S. [1 ]
Soudy, H. [1 ]
Darwish, A. [1 ]
Salam, M. Abdel [1 ]
Elhassan, T. [2 ]
Rehman, A. [2 ]
Bakshi, N. [1 ]
Maghfoor, I. [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Oncol Res Unit, Riyadh, Saudi Arabia
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3635
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
  • [1] International Prognostic Index (IPI) is a stronger predictor of outcome in diffuse large B cell lymphoma (DLBCL) treated with rituximab (R) and CHOP (R-CHOP) compared to revised-IPI (R-IPI)
    Soudy, H.
    Bakshi, N.
    Darwish, A.
    Salam, M. Abdel
    Rehman, A.
    Elhassan, T.
    Akhtar, S.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S846 - S846
  • [2] Revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-Cell lymphoma (DLBCL) treated with rituximab and CHOP (R-CHOP).
    Sehn, LH
    Chhanabhai, M
    Fitzgerald, C
    Gill, K
    Hoskins, P
    Klasa, R
    Savage, K
    Shenkier, T
    Sutherland, J
    Wilson, K
    Gascoyne, RD
    Connors, JM
    BLOOD, 2005, 106 (11) : 147A - 147A
  • [3] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    HAEMATOLOGICA, 2016, 101 : 686 - 687
  • [4] LYMPHOCYTOPENIA MAY ADD TO THE PREDICTION ACHIEVED BY THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T.
    Anastasopoulou, A.
    Pangalis, G.
    Constantinou, N.
    Stavroulaki, E.
    Karakatsanis, S.
    Papageorgiou, S.
    Sachanas, S.
    Pappi, V.
    Tsirkinidis, P.
    Moschoyianni, M.
    Kyrtsonis, M.
    Kokoris, S.
    Kalpadakis, C.
    Siakantaris, M.
    Dimou, M.
    Georgiou, G.
    Konstantinidou, P.
    Dervenoulas, J.
    Roussou, P.
    Papadaki, H.
    Panayiotidis, P.
    Beris, P.
    Angelopoulou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 280 - 280
  • [5] RITUXIMAB-CHOP (R-CHOP) IN THE TREATMENT OF 441 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: OUTCOME AND PROGNOSTIC FACTORS FOCUSING TO THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI)
    Vassilakopoulos, T. P.
    Pangalis, G. A.
    Anastasopoulou, A.
    Angelopoulou, M. K.
    Dimou, M.
    Stavroulaki, E.
    Karakatsanis, S.
    Kalpadakis, C.
    Sachanas, S.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Yiakoumis, X.
    Roussou, P.
    Panayiotidis, P.
    Papadaki, H.
    Constantinou, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 163 - 164
  • [6] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [7] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Proctor, B. R.
    Hui, D.
    Donaldson, J.
    Savage, K. J.
    Shenkier, T. N.
    Hoskins, P. J.
    Klasa, R.
    Randy, G.
    Joseph, C.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population
    Shen Yang
    Yao Yu
    Li Jun-Min
    Mi Jian-Qing
    Chen Qiu-Sheng
    Chen Yu
    Zhao Wei-Li
    You Jian-Hua
    Zhao Hui-Jin
    Wang Yan
    Wang Li
    Cheng Shu
    Shen Zhi-Xiang
    ANNALS OF HEMATOLOGY, 2009, 88 (09) : 863 - 869
  • [9] Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population
    Shen Yang
    Yao Yu
    Li Jun-Min
    Mi Jian-Qing
    Chen Qiu-Sheng
    Chen Yu
    Zhao Wei-Li
    You Jian-Hua
    Zhao Hui-Jin
    Wang Yan
    Wang Li
    Cheng Shu
    Shen Zhi-Xiang
    Annals of Hematology, 2009, 88 : 863 - 869
  • [10] Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Ye, Byeong Jin
    Moon, Joon Ho
    Jo, Jae-Cheol
    Lee, Won Sik
    Shin, Ho-Jin
    Oh, Sun Young
    Kim, Yang Soo
    BLOOD, 2013, 122 (21)
12345